Faculty of Nursing, Clinical Sciences Building, University of Alberta, Edmonton, Alberta, Canada.
Implement Sci. 2009 Oct 13;4:65. doi: 10.1186/1748-5908-4-65.
Despite recent research supporting the use of metered dose inhalers with spacer devices (MDI/spacers) in pediatric emergency departments (PEDs) for acute exacerbations of asthma, uptake of this practice has been slow. The objectives of this study were to determine the barriers and supports to implementing MDI/spacer research and to identify factors associated with early and late adoption of MDI/spacers in Canadian PEDs.
Using a comparative case study design, we classified nine tertiary care pediatric hospital PEDs based on their stage of implementation. Data were collected using focus group interviews with physicians, registered nurses (RNs), and respiratory therapists (RTs), and individual interviews with both patient care and medical directors at each site. Initial coding was based on the Ottawa Model of Research Use (OMRU) categories of elements known to influence the uptake of innovations.
One hundred and fifty healthcare professionals from nine different healthcare institutions participated in this study. Lack of leadership in the form of a research champion, a lack of consensus about the benefits of MDI/spacers among staff, perceived resistance from patients/parents, and perceived increased cost and workload associated with MDI/spacer use were the most prevalent barriers to the adoption of the MDI/spacer. Common strategies used by early-adopting sites included the active participation of all professional groups in the adoption process in addition to a well-planned and executed educational component for staff, patients, and families. Early adopter sites were also more likely to have the MDI/spacer included in a clinical protocol/pathway.
Potential barriers and supports to implementation have been identified that will help EDs adopt MDI/spacer use. Future interventions intended to increase MDI/spacer use in PEDs will need to be sensitive to the barriers identified in this study.
尽管最近的研究支持在儿科急诊部门(PED)中使用带喷雾器的计量吸入器(MDI/喷雾器)治疗哮喘急性发作,但这种做法的采用速度一直很慢。本研究的目的是确定在儿科急诊部门实施 MDI/喷雾器的障碍和支持因素,并确定与加拿大 PED 中 MDI/喷雾器早期和晚期采用相关的因素。
使用比较案例研究设计,我们根据实施阶段将 9 个三级护理儿科医院 PED 进行分类。通过对每个地点的医生、注册护士(RN)和呼吸治疗师(RT)进行焦点小组访谈以及对患者护理和医疗主任进行个别访谈收集数据。初始编码基于影响创新采用的渥太华研究利用模型(OMRU)的元素类别。
来自 9 个不同医疗机构的 150 名医疗保健专业人员参与了这项研究。缺乏研究冠军形式的领导力、员工对 MDI/喷雾器益处缺乏共识、患者/家长感知的阻力以及与 MDI/喷雾器使用相关的感知成本和工作量增加是采用 MDI/喷雾器的最常见障碍。早期采用者使用的常见策略包括所有专业团体积极参与采用过程,以及为员工、患者和家属制定并执行良好的教育计划。早期采用者的 PED 更有可能将 MDI/喷雾器纳入临床方案/路径。
已经确定了实施的潜在障碍和支持因素,这将有助于 ED 采用 MDI/喷雾器的使用。未来旨在增加 PED 中 MDI/喷雾器使用的干预措施需要对本研究中确定的障碍敏感。